Kangmei Pharma | 600518 - 負債

株価
1.86
毎日の変更
0 0%
毎月
-3.13%
毎年
-13.08%
Q1 予測
1.86




負債 変化する 日付
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Avita Medical AUD 46.05M 1.46M 2025-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Dianthus Therapeutics USD 1.28M 45K 2025-09
Genomma Lab Internacional MXN 7.2B 242.7M 2025-06
Hypermarcas BRL 8.86B 535.71M 2025-06
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
IQVIA Holdings USD 15.72B 767M 2025-12
Jiangsu Hengrui CNY 91.43M 17.24M 2025-06
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Moderna USD 734M 7M 2025-09
Organon & Co USD 8.83B 68M 2025-09
Revvity USD 3.37B 5.86M 2025-09
Sh Fosun Pharma CNY 36.99B 176.57M 2025-06
Tectonic Therapeutic USD 876K 115K 2024-12
Viatris USD 14.41B 25.6M 2025-12
Wuxi Apptec CNY 7.52B 1.06B 2025-06
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Zz Pientze Pharmaceu CNY 1.07B 52.69M 2025-06